American Cancer Society. Cancer facts & figures 2015. Atlanta: American Cancer Society; 2015.
Google Scholar
Cortes JE, Talpaz M, O’Brien S, Faderl S, Garcia-Manero G, Ferrajoli A, et al. Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal. Cancer. 2006;106(6):1306–15.
Article
CAS
Google Scholar
Rohrbacher M, Hasford J. Epidemiology of chronic myeloid leukaemia (CML). Best Pract Res Clin Haematol. 2009;22(3):295–302.
Article
Google Scholar
Mendizabal AM, Garcia-Gonzalez P, Levine PH. Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low and middle income countries. Cancer Epidemiol. 2013;37(3):247–54.
Article
Google Scholar
Au WY, Caguioa PB, Chuah C, Hsu SC, Jootar S, Kim DW, et al. Chronic myeloid leukemia in Asia. Int J Hematol. 2009;89(1):14–23.
Article
Google Scholar
Hoglund M, Sandin F, Simonsson B. Epidemiology of chronic myeloid leukaemia: an update. Ann Hematol. 2015;94(Suppl 2):S241–7.
Article
Google Scholar
Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, et al. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950–2001. Radiat Res. 2013;179(3):361–82.
Article
CAS
Google Scholar
Kabat GC, Wu JW, Moore SC, Morton LM, Park Y, Hollenbeck AR, et al. Lifestyle and dietary factors in relation to risk of chronic myeloid leukemia in the NIH-AARP Diet and Health Study. Cancer Epidemiol Biomarkers Prev. 2013;22(5):848–54.
Article
CAS
Google Scholar
Lauseker M, Hasford J, Saussele S, Kremers S, Kraemer D, Linemann W, et al. Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death. Cancer. 2017;123(13):2467–71.
Article
CAS
Google Scholar
Leibowitz D, Young KS. The molecular biology of CML: a review. Cancer Invest. 1989;7(2):195–203.
Article
CAS
Google Scholar
Giri S, Pathak R, Martin MG, Bhatt VR. Characteristics and survival of BCR/ABL negative chronic myeloid leukemia: a retrospective analysis of the surveillance, epidemiology and end results database. Ther Adv Hematol. 2015;6(6):308–12.
Article
CAS
Google Scholar
Dudley J, Chambers T. Why the resistance to diagnostic imaging in childhood urinary tract infections. Lancet. 1996;348(9020):71–2.
Article
CAS
Google Scholar
Stagno G, Stella S, Spitaleri A, Pennisi MS, Di Raimondo F, Vigneri P. Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes. Expert Rev Anticancer Ther. 2016;16(3):273–8.
Article
CAS
Google Scholar
Jabbour E, Kantarjian H, Cortes J. Use of second- and third-generation tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia: an evolving treatment paradigm. Clin Lymphoma Myeloma Leuk. 2015;15(6):323–34.
Article
Google Scholar
Bower H, Bjorkholm M, Dickman PW, Hoglund M, Lambert PC, Andersson TM. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population. J Clin Oncol. 2016;34(24):2851–7.
Article
CAS
Google Scholar
Mandal E, Bolt DM, Shah BK. Disparities in chronic myeloid leukemia survival by age, gender, and ethnicity in pre- and post-imatinib eras in the US. Acta Oncol. 2013;52(4):837–41.
Article
Google Scholar
Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 2010;102(3):83–7.
PubMed
CAS
Google Scholar
Statistics Canada. Table 17-10-0078-01 Annual demographic estimates by census metropolitan area, age and sex, based on the Standard Geographical Classification (SGC). 2011. https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710007801. Accessed 3 Oct 2018.
Boniol M, Heanue M. Age-standardisation and denominators. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P, editors. Cancer incidence in five continents, IARC scientific publication no160, vol. 9. Lyon: International Agency for Research on Cancer, World Health Organization; 2008. p. 99–101.
Google Scholar
Statistics Canada. Table 17-10-0005-01 Population estimates on July 1st, by age and sex. https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710000501. Accessed 3 Oct 2018.
Craig BM, Rollison DE, List AF, Cogle CR. Underreporting of myeloid malignancies by United States cancer registries. Cancer Epidemiol Biomarkers Prev. 2012;21(3):474–81.
Article
Google Scholar
Kim HI, Lim H, Moon A. Sex differences in cancer: epidemiology, genetics and therapy. Biomol Ther (Seoul). 2018;26(4):335–42.
Article
Google Scholar
Chen Y, Wang H, Kantarjian H, Cortes J. Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009. Leuk Lymphoma. 2013;54(7):1411–7.
Article
Google Scholar
Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724–34.
Article
CAS
Google Scholar
Osorio S, Casado LF, Giraldo P, Maestro B, Andrade M, Redondo S, et al. Chronic myeloid leukaemia in Spain: its presentation characteristics have changed. Spanish section of the EUTOS population-based registry. Rev Clin Esp. 2016;216(6):293–300.
Article
CAS
Google Scholar
Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type: a report from the haematological malignancy research network. Br J Cancer. 2011;105(11):1684–92.
Article
CAS
Google Scholar
Beinortas T, Tavoriene I, Zvirblis T, Gerbutavicius R, Jurgutis M, Griskevicius L. Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000–2013. BMC Cancer. 2016;16:198.
Article
CAS
Google Scholar
Kulikov SM, Vinogradova O, Chelysheva E, Tishchenko IA, Galaiko MA, Lazareva OV, et al. [Incidence of chronic myeloid leukemia in 6 regions of Russia according to the data of the 2009–2012 population-based study]. Ter Arkh. 2014;86(7):24–30 (Russian).
PubMed
CAS
Google Scholar
Dikshit RP, Nagrani R, Yeole B, Koyande S, Banawali S. Changing trends of chronic myeloid leukemia in greater Mumbai, India over a period of 30 years. Indian J Med Paediatr Oncol. 2011;32(2):96–100.
Article
Google Scholar